Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck KGaA ‘Consumer Centric’ Model Boosts Product Lines, Shapes R&D

This article was originally published in The Tan Sheet

Executive Summary

Merck KGaA launches additional OTC products from brands associated with doctors or behind-the-counter sales or that currently are Rx to yield double-digit organic growth. The German firm is soliciting consumer feedback to shape its R&D and improve its understanding of factors driving the OTC market.

You may also be interested in...



Merck KGaA Consumer Engages Social Media To Grow In Europe, Latin America

The German firm will expand its digital engagement strategy, having achieving strong followings with the strategy for three brands in Europe and/or Latin America. Initiative reflects company's larger "consumerization" strategy.

Merck KGaA Consumer Engages Social Media To Grow In Europe, Latin America

The German firm will expand its digital engagement strategy, having achieving strong followings with the strategy for three brands in Europe and/or Latin America. Initiative reflects company's larger "consumerization" strategy.

Climb In Consumer Self-Care, Slide In Rx Margin Boost Front-Of-Store Pharmacy Sales

OTC drug and supplement marketers could benefit from stronger outreach to independent pharmacists, via product education and patient sales collateral, pharmacists say in a Healthcare Distribution Management Association survey.

Topics

Related Companies

UsernamePublicRestriction

Register

LL055695

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel